DYNEX Demonstrates DYNABLOT Automatic Analyzer for Immunoblot and Westernblot Methods
By LabMedica International staff writers Posted on 19 Nov 2019 |

Image: Fully automatic analyzer for immunoblot and westernblot methods (Photo courtesy of Dynex Technologies)
DYNEX Technologies (Prague, Czech Republic) demonstrated its DYNABLOT automatic analyzer for immunoblot and Western blot methods at this year's MEDICA, the world's largest annual medical technology trade fair, which took place from 18-21 November in Düsseldorf, Germany. At the 2019 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries.
The increasing digitalization of processes in the healthcare economy was a major topic at this year's MEDICA and was represented by exhibitors at the event as well as reflected in the programs of the accompanying conferences and forums. A new feature this year was a new allocation of themes in the exhibition halls. Due to the increasing convergence of software and hardware, especially in the field of medical technology, the halls for the MEDICA segment of information and communication technology was moved to make it directly connected to the halls for medical technology and electromedicine. Manufacturers of surgical instruments were moved to halls that brought them thematically closer to providers of imaging technology (e.g. endoscopy) as well as complete solutions for modern hybrid operating rooms.
DYNEX, a supplier of laboratory equipment and related services, primarily focuses on the sale of instruments, diagnostics and other reagents for immunochemical, molecular-biological and microbiological laboratories. DYNEX specializes in the following methods: ELISA, immunoblot and Western blot, immunofluorescence assay (IFA), PCR, hybridization, electrophoresis, microarray, next-generation sequencing, lateral-flow immunoassay (LFIA), immunoprecipitation, cultivation and cell growth curves measurements.
At the 2019 edition of MEDICA, DYNEX demonstrated its DYNABLOT fully automated analyzer for immunoblot and Western blot methods. The system fully automates blot pro- cessing starting with samples being pipetted and finishes with camera image capture. Only insertion of samples in primary tubes and strips are required from an operator. The instrument is fitted with reagents peristaltic pumps located at its front for easy use and handling. The pumps are capable of running in reverse. It assists the functions “Antidrop” (no drops at the end of tubing during dispensing) and “Reagents saving” (aspiration of dead volume back to reagent bottles after last dis-pensing).
The mixing of strip content during incubation is assisted by rocking the strip plate. Slow, medium or fast rocking speeds can be selected. Used liquid media is removed by an integrated vacuum pump and then directed to a waste bottle with a level sensor. Its compact dimensions (800 x 500 x 540 mm), weight (35 kg), and very quiet running make it friendly to laboratory environments.
Related Links:
Dynex Technologies
The increasing digitalization of processes in the healthcare economy was a major topic at this year's MEDICA and was represented by exhibitors at the event as well as reflected in the programs of the accompanying conferences and forums. A new feature this year was a new allocation of themes in the exhibition halls. Due to the increasing convergence of software and hardware, especially in the field of medical technology, the halls for the MEDICA segment of information and communication technology was moved to make it directly connected to the halls for medical technology and electromedicine. Manufacturers of surgical instruments were moved to halls that brought them thematically closer to providers of imaging technology (e.g. endoscopy) as well as complete solutions for modern hybrid operating rooms.
DYNEX, a supplier of laboratory equipment and related services, primarily focuses on the sale of instruments, diagnostics and other reagents for immunochemical, molecular-biological and microbiological laboratories. DYNEX specializes in the following methods: ELISA, immunoblot and Western blot, immunofluorescence assay (IFA), PCR, hybridization, electrophoresis, microarray, next-generation sequencing, lateral-flow immunoassay (LFIA), immunoprecipitation, cultivation and cell growth curves measurements.
At the 2019 edition of MEDICA, DYNEX demonstrated its DYNABLOT fully automated analyzer for immunoblot and Western blot methods. The system fully automates blot pro- cessing starting with samples being pipetted and finishes with camera image capture. Only insertion of samples in primary tubes and strips are required from an operator. The instrument is fitted with reagents peristaltic pumps located at its front for easy use and handling. The pumps are capable of running in reverse. It assists the functions “Antidrop” (no drops at the end of tubing during dispensing) and “Reagents saving” (aspiration of dead volume back to reagent bottles after last dis-pensing).
The mixing of strip content during incubation is assisted by rocking the strip plate. Slow, medium or fast rocking speeds can be selected. Used liquid media is removed by an integrated vacuum pump and then directed to a waste bottle with a level sensor. Its compact dimensions (800 x 500 x 540 mm), weight (35 kg), and very quiet running make it friendly to laboratory environments.
Related Links:
Dynex Technologies
Latest Medica 2019 News
- Mast Group Introduces New MAST CARBA PAcE for Rapid Carbapenemase Detection
- DRG Instruments Demonstrates DRG:HYBRID-XL Fully Automated Lab Analyzer
- Diatron Introduces New Aquila 5Dretic 5-Part Differential Hematology Analyzer
- Alifax S.r.l. Highlights First Automated System for Bacterial Culture and Susceptibility Testing
- Erba Mannheim Showcases New Launches at MEDICA 2019
- EUROIMMUN Showcases Immunoassay Testing Products at MEDICA 2019
- Diconex S.A. Exhibits InCCA Intelligent Clinical Chemistry Analyzer at MEDICA 2019
- Chembio Diagnostics Showcases New DPP Line of Rapid Tests at MEDICA 2019
- Systec Launches New and Improved HX-150 Autoclave at MEDICA 2019
- TaiDoc Showcases Multi-Parameter Monitoring Systems and Advanced Devices
- IDS Exhibits Next Generation Automated Immunoanalyzer IDS-i10 at MEDICA 2019
- JEOL Ltd. Introduces BioMajesty Series of Clinical Chemistry Analyzers at MEDICA 2019
- EKF Diagnostics Showcases Full Product Range at MEDICA 2019
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Revolutionary Blood Test Detects 30 Different Types of Cancers with 98% Accuracy
With cancer expected to become the leading cause of global mortality by 2030, early detection remains the most effective strategy to reduce death rates. Current screening methods only cover five types... Read more
Simple Blood Test Better Predicts Heart Disease Risk
Cardiovascular diseases (CVDs) are the primary cause of death worldwide. A large proportion of these cases could be prevented by addressing lifestyle and environmental factors such as smoking, poor diet,... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more